Chronic and acute pain and pain management for patients in methadone maintenance treatment

American Journal on Addictions

Volumn 22, Issue 1, 2013, Pages 75-83

  Eyler, Elizabeth C H ^a  

^a JBS International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DEXTROMETHORPHAN; GABAPENTIN; IBUPROFEN; ILLICIT DRUG; METHADONE; MORPHINE; OPIATE; OXYCODONE PLUS PARACETAMOL; PLACEBO; REMIFENTANIL;

ANALGESIC ACTIVITY; CHRONIC PAIN; COLD PRESSOR PAIN; COPING BEHAVIOR; DELIVERY; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; ELECTROSTIMULATION; HUMAN; HYPERALGESIA; LABOR PAIN; METHADONE TREATMENT; NEUROPATHIC PAIN; NOCICEPTION; OPIATE ADDICTION; PAIN; PAIN THRESHOLD; PATIENT CARE; POSTPARTUM PAIN; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY OF LIFE; RESPIRATION DEPRESSION; REVIEW; SOCIAL INTERACTION;

ACUTE PAIN; ANALGESICS; CATASTROPHIZATION; CHRONIC PAIN; DRUG TOLERANCE; FEMALE; HUMANS; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PAIN THRESHOLD; PREGNANCY; PREGNANCY COMPLICATIONS; SELF MEDICATION;

EID: 84873648168     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2013.00308.x     Document Type: Review

References (61)

1. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA. 2000; 284: 1689-1695.
2. Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume II. Technical appendices and selected prevalence tables. Rockville, MD: Office of Applied Studies; 2010. NSDUH Series H-38B, HHS Publication No. (SMA) 10-4856.
3. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Unintentional drug poisoning in the United States. Washington, DC: Division of Unintentional Injury Prevention; 2010.
4. Manchikanti L, Fellows B, Ailinani H, et al. Therapeutic use, abuse, and nonmedical use of opioids: A ten-year perspective. Pain Physician. 2010; 13: 401-435.
5. Center for Substance Abuse Treatment. Medication-assisted treatment for opioid addiction in opioid treatment programs. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. Treatment Improvement Protocol (TIP) Series 43. HHS Publication No. (SMA) 05-4048.
6. Potter JS, Prather K, Weiss RD., Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict. 2008; 17: 121-125.
7. Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003; 289: 2370-2378.
8. Alford DP, Compton P, Samet JH., Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006; 144: 127-134.
9. Mehta V, Langford RM., Acute pain management for opioid dependent patients. Anaesthesia. 2006; 61: 269-276.
10. Mitchell AM, Dewey CM., Chronic pain in patients with substance abuse disorder: General guidelines and an approach to treatment. Postgrad Med. 2008; 120: 75-79.
11. Peng PW, Tumber PS, Gourlay D., Review article: Perioperative pain management of patients on methadone therapy. Can J Anaesth. 2005; 52: 513-523.
12. Scimeca MM, Savage SR, Portenoy R, et al. Treatment of pain in methadone-maintained patients. Mt Sinai J Med. 2000; 67: 412-422.
13. Athanasos P, Smith CS, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain. 2006; 120: 267-275.
14. Compton P, Charuvastra VC, Kintaudi K, et al. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage. 2000; 20: 237-245.
15. Doverty M, Somogyi AA, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain. 2001; 93: 155-163.
16. Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain. 2001; 90: 91-96.
17. Hay JL, White JM, Bochner F, et al. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J Pain. 2009; 10: 316-322.
18. Peles E, Schreiber S, Hetzroni T, et al. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. J Pain. 2011; 12: 41-50.
19. Prosser JM, Steinfeld M, Cohen LJ, et al. Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance. Drug Alcohol Depend. 2008; 95: 237-244.
20. Blinderman CD, Sekine R, Zhang B, et al. Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs). J Opioid Manag. 2009; 5: 107-114.
21. Hay JL, White JM, Bochner F, et al. Antinociceptive effects of high-dose remifentanil in male methadone-maintained patients. Eur J Pain. 2008; 12: 926-933.
22. Peles E, Schreiber S, Gordon J, et al. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005; 113: 340-346.
23. Barry DT, Beitel M, Cutter CJ, et al. Allopathic, complementary, and alternative medical treatment utilization for pain among methadone-maintained patients. Am J Addict. 2009; 18: 379-385.
24. Barry DT, Beitel M, Cutter CJ, et al. Conventional and non-conventional pain treatment utilization among opioid dependent individuals with pain seeking methadone maintenance treatment: A needs assessment study. J Addict Med. 2009; 18: 379-385.
25. Barry DT, Beitel M, Joshi D, et al. Pain and substance-related pain-reduction behaviors among opioid dependent individuals seeking methadone maintenance treatment. Am J Addict. 2009; 18: 117-121.
26. Jamison RN, Kauffman J, Katz NP., Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000; 19: 53-62.
27. Berg KM, Arnsten JH, Sacajiu G, et al. Providers' experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med. 2009; 24: 482-488.
28. Trafton JA, Oliva EM, Horst DA, et al. Treatment needs associated with pain in substance use disorder patients: Implications for concurrent treatment. Drug Alcohol Depend. 2004; 73: 23-31.
29. Johannes CB, Le TK, Zhou X, et al. The prevalence of chronic pain in United States adults: Results of an Internet-based survey. J Pain. 2010; 11: 1230-1239.
30. National Center for Health Statistics. Health, United States, 2006: With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2006.
31. Brewer DD, Catalano RF, Haggerty K, et al. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction. 1998; 93: 73-92.
32. Mancino M, Curran G, Han X, et al. Predictors of attrition from a national sample of methadone maintenance patients. Am J Drug Alcohol Abuse. 2010; 36: 155-160.
33. Barry DT, Beitel M, Garnet B, et al. Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients. J Clin Psychiatry. 2009; 70: 1213-1218.
34. Ilgen MA, Trafton JA, Humphreys K., Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend. 2006; 82: 187-193.
35. Lee M, Silverman SM, Hansen H, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011; 14: 145-161.
36. Silverman SM., Opioid induced hyperalgesia: Clinical implications for the pain practitioner. Pain Physician. 2009; 12: 679-684.
37. Chu LF, Clark DJ, Angst MS., Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain. 2006; 7: 43-48.
38. Pud D, Cohen D, Lawental E, et al. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend. 2006; 82: 218-223.
39. Younger J, Barelka P, Carroll I, et al. Reduced cold pain tolerance in chronic pain patients following opioid detoxification. Pain Med. 2008; 9: 1158-1163.
40. Le Bars D, Villanueva L, Bouhassira D, et al. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol Fiziol Eksp Ter. 1992; 55-65.
41. Campbell CM, Edwards RR., Mind-body interactions in pain: The neurophysiology of anxious and catastrophic pain-related thoughts. Transl Res. 2009; 153: 97-101.
42. Quartana PJ, Campbell CM, Edwards RR., Pain catastrophizing: A critical review. Expert Rev Neurother. 2009; 9: 745-758.
43. Garnet B, Beitel M, Cutter CJ, et al. Pain catastrophizing and pain coping among methadone-maintained patients. Pain Med. 2011; 12: 79-86.
44. Karasz A, Zallman L, Berg K, et al. The experience of chronic severe pain in patients undergoing methadone maintenance treatment. J Pain Symptom Manage. 2004; 28: 517-525.
45. Passik SD, Hays L, Eisner N, et al. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother. 2006; 20: 5-13.
46. Rosenblum A, Parrino M, Schnoll SH, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007; 90: 64-71.
47. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA. 2002; 287: 337-344.
48. Abrams DI, Couey P, Shade SB, et al. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011; 90: 844-851.
49. Elikkottil J, Gupta P, Gupta K., The analgesic potential of cannabinoids. J Opioid Manag. 2009; 5: 341-357.
50. McCance-Katz EF, Sullivan LE, Nallani S., Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: A review. Am J Addict. 2010; 19: 4-16.
51. Weschules DJ, Bain KT, Richeimer S., Actual and potential drug interactions associated with methadone. Pain Med. 2008; 9: 315-344.
52. Compton P, Kehoe P, Sinha K, et al. Gabapentin improves cold-pressor pain responses in methadone-maintained patients. Drug Alcohol Depend. 2010; 109: 213-219.
53. Compton PA, Ling W, Torrington MA., Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients. Addict Biol. 2008; 13: 393-402.
54. Wachholtz A, Ziedonis D, Gonzalez G., Comorbid pain and opioid addiction: Psychosocial and pharmacological treatments. Subst Use Misuse. 2011; 46: 1536-1552.
55. Jones HE, O'Grady K, Dahne J, et al. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse. 2009; 35: 151-156.
56. Greenwald MK, Johanson CE, Moody DE, et al. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers. Neuropsychopharmacology. 2003; 28: 2000-2009.
57. Meyer M, Wagner K, Benvenuto A, et al. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstet Gynecol. 2007; 110: 261-266.
58. Hines S, Theodorou S, Williamson A, et al. Management of acute pain in methadone maintenance therapy in-patients. Drug Alcohol Rev. 2008; 27: 519-523.
59. Rowley D, McLean S, O'Gorman A, et al. Review of cancer pain management in patients receiving maintenance methadone therapy. Am J Hosp Palliat Care. 2011; 28: 183-187.
60. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009; 10: 113-130.
61. Cruciani RA, Esteban S, Seewald RM, et al. MMTP patients with chronic pain switching to pain management clinics: A problem or an acceptable practice ? Pain Med. 2008; 9: 359-364.